Table 4.
Organism | PEN | CRO | VAN | MEM | DOX | SXT | CLI | LZD | CIP | ERY | RIF | GEN | TET |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C. striatum (n = 13) | 0/13 | 0/13 | 13/13 | 5/13 | 0/5 | 0/5 | 1/3 | 5/5 | 0/3 | 1/3 | 3/3 | 1/1 | 0/1 |
C. jeikeium (n = 3) | 0/3 | 0/3 | 3/3 | 0/3 | 1/1 | 0/1 | … | 1/1 | … | … | … | … | … |
C. amycolatum (n = 2) | 0/2 | 1/2 | 2/2 | 0/2 | 1/1 | 1/1 | 0/1 | 1/1 | … | … | … | … | … |
Susceptibilities reported as total number of susceptible isolates/total number of tested isolates. The default AST in our laboratory includes penicillin, ceftriaxone, meropenem, and vancomycin. Additional antibiotic testing was requested for 7 isolates and included doxycycline, trimethoprim-sulfamethoxazole, clindamycin, linezolid, ciprofloxacin, erythromycin, rifampin, and gentamicin. Additionally, susceptibilities to agents without interpretative guidelines such as amoxicillin-clavulanate, moxifloxacin, levofloxacin, daptomycin, tigecycline, and minocycline were occasionally ordered (refer to Supplementary Table 2 for MICs).
Abbreviations: CIP, ciprofloxacin; CLI, clindamycin; CRO, ceftriaxone; DOX, doxycycline; ERY, erythromycin; GEN, gentamicin; LZD, linezolid; MEM, meropenem; MIC, minimum inhibitory concentration; PEN, penicillin; RIF, rifampin; SXT, trimethoprim sulfamethoxazole; TET, tetracycline; VAN, vancomycin.